Financial statements Advasol
Balance sheet data of ADVASOL
Year
|
2021
|
2023
|
---|---|---|
Total assets | 652 803,67 | 853 468,65 |
A. Fixed assets | 48 045,53 | 59 711,39 |
B. Current assets | 604 758,14 | 793 757,26 |
C. Share capital contributions (basic funds) | - | - |
D. Own shares (stocks) | - | - |
Total liabilities | 652 803,67 | 853 468,65 |
A. Equity | 93 951,34 | 313 410,01 |
B. Liabilities and provisions for liabilities | 558 852,33 | 540 058,64 |
I. Long-term liabilities | 0,00 | - |
II. Short-term liabilities | 358 852,33 | 197 308,64 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.